ES400623A1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ES400623A1
ES400623A1 ES400623A ES400623A ES400623A1 ES 400623 A1 ES400623 A1 ES 400623A1 ES 400623 A ES400623 A ES 400623A ES 400623 A ES400623 A ES 400623A ES 400623 A1 ES400623 A1 ES 400623A1
Authority
ES
Spain
Prior art keywords
hydrogen atom
therapeutically effective
formula
acid derivative
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES400623A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES400623A1 publication Critical patent/ES400623A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Procedure for the preparation of a pharmaceutical composition, characterized in that a therapeutically effective penicillin is mixed with a penicilloilic acid derivative of the general formula ** (See formula) ** in which X represents a hydrogen atom or a group of the formula R1-NH-, in which R1 represents a hydrogen atom or a lower acyl group, n represents an integer of value 1 to 4 and R represents an organic radical that is a therapeutically effective penicillin substituent, or a salt of said acid derivative. (Machine-translation by Google Translate, not legally binding)
ES400623A 1971-03-11 1972-03-10 Pharmaceutical compositions Expired ES400623A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH355871 1971-03-11

Publications (1)

Publication Number Publication Date
ES400623A1 true ES400623A1 (en) 1975-02-01

Family

ID=4258572

Family Applications (2)

Application Number Title Priority Date Filing Date
ES400624A Expired ES400624A1 (en) 1971-03-11 1972-03-10 Pharmaceutical compositions
ES400623A Expired ES400623A1 (en) 1971-03-11 1972-03-10 Pharmaceutical compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES400624A Expired ES400624A1 (en) 1971-03-11 1972-03-10 Pharmaceutical compositions

Country Status (21)

Country Link
AT (2) AT312802B (en)
AU (1) AU461136B2 (en)
BE (2) BE780472A (en)
CA (1) CA972759A (en)
CH (1) CH546783A (en)
DE (2) DE2211420A1 (en)
DK (1) DK136977B (en)
ES (2) ES400624A1 (en)
FI (1) FI52345C (en)
FR (2) FR2128823B1 (en)
GB (2) GB1322149A (en)
HK (1) HK14676A (en)
HU (2) HU166712B (en)
IE (2) IE36203B1 (en)
IL (2) IL38865A (en)
NL (2) NL7202772A (en)
NO (1) NO138142C (en)
PH (2) PH12264A (en)
SE (3) SE406198B (en)
YU (1) YU35011B (en)
ZA (2) ZA721364B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316882A (en) * 1978-04-20 1982-02-23 Levine Bernard B Compositions for testing to predict and/or diagnose allergy to penicillins
CA1209477A (en) * 1981-03-26 1986-08-12 Bruce E. Haeger Composition of matter comprising a lyophilized preparation of a penicillin derivative

Also Published As

Publication number Publication date
SE7514031L (en) 1975-12-11
NL7202772A (en) 1972-09-13
NO138142C (en) 1978-07-12
GB1322149A (en) 1973-07-04
FR2128824B1 (en) 1975-06-13
FR2128823B1 (en) 1975-04-25
AT312802B (en) 1974-01-25
CA972759A (en) 1975-08-12
BE780471A (en) 1972-09-11
IL38865A (en) 1975-08-31
DK136977B (en) 1977-12-27
AU461136B2 (en) 1975-04-30
IE36204L (en) 1972-09-11
IL38864A (en) 1975-08-31
FI52345C (en) 1977-08-10
FR2128823A1 (en) 1972-10-20
AT331389B (en) 1976-08-25
IE36204B1 (en) 1976-09-15
ES400624A1 (en) 1975-02-01
IL38864A0 (en) 1972-05-30
FR2128824A1 (en) 1972-10-20
HK14676A (en) 1976-03-26
IE36203B1 (en) 1976-09-15
NO138142B (en) 1978-04-03
FI52345B (en) 1977-05-02
IL38865A0 (en) 1972-05-30
DK136977C (en) 1978-06-05
ZA721363B (en) 1972-11-29
PH9295A (en) 1975-08-15
ATA188672A (en) 1975-11-15
NL7202771A (en) 1972-09-13
IE36203L (en) 1972-09-11
DE2211419A1 (en) 1972-09-21
BE780472A (en) 1972-09-11
ZA721364B (en) 1972-11-29
AU3957172A (en) 1973-09-06
GB1333524A (en) 1973-10-10
YU35011B (en) 1980-06-30
CH546783A (en) 1974-03-15
HU165203B (en) 1974-07-27
SE406198B (en) 1979-01-29
PH12264A (en) 1978-12-12
DE2211420A1 (en) 1972-09-21
YU62572A (en) 1979-12-31
HU166712B (en) 1975-05-28
SE7513807L (en) 1975-12-08

Similar Documents

Publication Publication Date Title
ES438946A2 (en) Vincaminic acid esters
ES400623A1 (en) Pharmaceutical compositions
ES451466A1 (en) 5-thiazole-methane-amines, and their use as antilipolytics
ES354173A1 (en) Tetracycline sulfamate and derivatives thereof
ES429020A1 (en) Certain 2-alkyl-5-oxymethylthiazoles
ES400414A1 (en) Procedure for the preparation of N-substituted piperidine derivatives and their use as stabilizers. (Machine-translation by Google Translate, not legally binding)
ES402328A1 (en) Preparation of 4-hydroxybenzodioxoles
ES390754A1 (en) 3-substituted-6-alkyl-2,3,6,9-tetrahydro-2,9-dioxothiazolo(5,4-f)-quinoline-8-carboxylic acids and methods for producing same
FR2290203B1 (en)
ES442051A1 (en) Aminoglycosides
ES418331A1 (en) Quinoline derivatives processes for their preparation and compo sitions incorporating them
ES290275A2 (en) Procedure for preparing new compounds for 6-methyl and 1,6-dimethyl-er-golina ii (Machine-translation by Google Translate, not legally binding)
ES361430A1 (en) Procedure for the preparation of effective compounds in the treatment of bronchospastic conditions. (Machine-translation by Google Translate, not legally binding)
ES410181A1 (en) Propoxyphene derivative
ES441029A1 (en) Acetylsalicylic acid derivatives their preparation and compo sitions containing them
ES279961A1 (en) Procedure for preparation of esteroid series of the strange and lumiestran series (Machine-translation by Google Translate, not legally binding)
GB1041694A (en) Substituted pyridine derivatives and preparation thereof
ES402381A1 (en) Substituted benzopyrans and processes for their preparation
ES351814A1 (en) Procedure for the preparation of canfosulphonates of derivatives of 2,6-dioxopurin. (Machine-translation by Google Translate, not legally binding)
ES413743A1 (en) A procedure for the preparation of l-alpha-hydrazino-beta-phenylpropionic acid compounds. (Machine-translation by Google Translate, not legally binding)
ES391431A1 (en) A procedure for the preparation of an N-phenyl carbamate compound. (Machine-translation by Google Translate, not legally binding)
ES332566A1 (en) A procedure for the preparation of a detergent composition. (Machine-translation by Google Translate, not legally binding)
ES402642A1 (en) Thiolcarbamates
ES296706A1 (en) A procedure for the preparation of 2-substituted benzofuran derivatives (Machine-translation by Google Translate, not legally binding)
ES399151A1 (en) Procedure for obtaining 4-piperidone-quetal derivatives, its preparation and its use as stabilizers. (Machine-translation by Google Translate, not legally binding)